SCHEMBL25796770

SCHEMBL25796770

Cc1c([N+](=O)[O-])ccc(N2CCCCC2)c1F

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.67
MAPT P10636 6/20 0.67
POLB P06746 4/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP2C9 P11712 1/20 0.55
GAA P10253 2/20 0.54
CTSB P07858 1/20 0.54
AR P10275 1/20 0.54
MAPK1 P28482 6/20 0.52
HPGD P15428 1/20 0.52
MEN1 O00255 1/20 0.52
USP2 O75604 1/20 0.52
TNNI3 P19429 1/20 0.52
TNNT2 P45379 1/20 0.52
TNNC1 P63316 1/20 0.52
KMT2A Q03164 1/20 0.52
LMNA P02545 3/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22471527 0.87 MAPT (0.54) ALDH1A1MAPTCYP1A2CYP2C19CYP2C9
SCHEMBL30464721 0.87 MAPT (0.54) ALDH1A1MAPTCYP1A2CYP2C19CYP2C9
SCHEMBL21031716 0.82 ALDH1A1 (0.67) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL8103840 0.81 ALDH1A1 (0.70) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL939398 0.80 ALDH1A1 (0.68) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL25796769 0.79 HTT (0.49) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL8484094 0.78 ALDH1A1 (0.62) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL23360737 0.78 ALDH1A1 (0.58) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL19700166 0.77 CTSB (0.55) ALDH1A1MAPTPOLBCYP1A2CYP2C19
SCHEMBL1636077 0.76 TDP1 (0.60) ALDH1A1MAPTCYP1A2HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691970-B2 Pyrazolopyridinone compounds JANSSEN PHARMACEUTICA NV (BE) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691970-B2 Pyrazolopyridinone compounds FGFR1, FGFR3, FGFR2 ALDH1A1 1418/4885MAPT 1516/4885POLB 2610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.